These results are consistent with others which have demonstrated deteriorations in lipid-lipoprotein profile, inflammatory status and measures of glucose-insulin homeostasis when central obesity exists concurrently with insulin resistance [31,32]. The gene discussed is INS; the disease is Abdominal obesity.